Related Experiment Video
Updated: May 13, 2026
09:37
Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
Published on: August 18, 2022
Imaging in patients with merkel cell carcinoma
Elisabeth Enzenhofer1, Philipp Ubl, Christian Czerny
1Department of Otolaryngology Head and Neck Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
Journal of Skin Cancer
|March 12, 2013
Summary
Merkel cell carcinoma (MCC), a rare and aggressive skin cancer, requires accurate nodal staging for patient outcomes. Emerging imaging techniques like FDG-PET/CT are becoming crucial for staging this challenging neuroendocrine tumor.
Area of Science:
- Oncology
- Dermatology
- Radiology
Background:
- Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine skin tumor with a high mortality rate.
- Accurate assessment of nodal involvement is critical for predicting patient outcomes in MCC.
- Limited published imaging reports and the absence of a standardized imaging algorithm hinder MCC staging.
Purpose of the Study:
- To review current imaging modalities for Merkel cell carcinoma staging.
- To highlight the increasing importance of sentinel lymph node biopsy and FDG-PET/CT in MCC management.
Main Methods:
- Review of existing literature on MCC imaging.
- Analysis of recommended primary staging procedures.
- Evaluation of emerging imaging techniques.
Main Results:
- Traditional staging includes ultrasonography, chest X-ray, CT, and MRI.
- Sentinel lymph node biopsy and FDG-PET/CT are increasingly recognized as important tools.
- No universally accepted imaging algorithm for MCC is currently available.
Conclusions:
- Accurate nodal staging is vital for Merkel cell carcinoma prognosis.
- FDG-PET/CT and sentinel node biopsy show promise for improved MCC staging.
- Further research is needed to establish a definitive imaging algorithm for MCC.